Supplementary Figure S4 from Development of a [<sup>89</sup>Zr]Zr-labeled Human Antibody using a Novel Phage-displayed Human scFv Library

Supplementary Figure 4. SDS-PAGE of eight unique purified human anti-TIP1 full-length IgGs under non-reducing (A) and reducing conditions (B). A. Intact full-length IgGs are observed above 150 kDa. B. In the reducing condition, heavy chains and light chains are observed at 50 kDa and 25 kDa, respectively.